Skip to main content
Caplight Logo









Beijing Tsingke Biotech Co., Ltd.

Beijing Tsingke Biotech Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://www.tsingke.com/

Last Round

Series B

Dec 5, 2022

Total Funding Raised

$88.71M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Beijing Tsingke Biotech Co., Ltd. is a biotechnology company that provides synthetic genomics products, life science research equipment, and biomanufacturing services for pharmaceutical, agricultural, and environmental science applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

oligonucleotide synthesisSanger sequencingnext-generation sequencingNGSgene synthesismolecular biology reagentspeptide synthesisgenomic research servicesCROCDMOcontract research organizationDNA sequencing servicebiotech lab serviceslab automationcodon optimizationgene factory

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Tsingke Biotech Co., Ltd. Comparables

Compare Beijing Tsingke Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Tsingke Biotech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BBI Life Sciences Corporation
88%
Shanghai Generay Biotech Co., Ltd.
84%
Synbio Technologies
82%

Beijing Tsingke Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 5, 2022
Series AJan 28, 2022
AngelMay 1, 2021

Beijing Tsingke Biotech Co., Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 141% MoM, from 1.5K to 3.6K.

  • Apr 16, 2026

    Monthly visitors increased 77% MoM, reaching 4.6K.

Beijing Tsingke Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing Tsingke Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing Tsingke Biotech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range11
Year FoundedN/A
Last FundingDec 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?